Study Stopped
Funding stopped
Living With Aphasia: An International Study
1 other identifier
observational
15
1 country
1
Brief Summary
This prospective cohort study hypothesizes that an analysis of parallel qualitative and quantitative data is necessary to examine the full experience of living with aphasia. It is also hypothesized that there are specific factors that act as barriers or facilitators to successfully living with aphasia. A unique aspect of the project is the use of the Assessment for Living with Aphasia (ALA), a new aphasia friendly measure based on the World Health Organization International Classification of Functioning, Disability and Health (WHO ICF). Each session will assess written and spoken language, functional communication, mobility, Activities of Daily Living (ADL) function, burden of stroke, quality of life, and depression.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 15, 2010
CompletedFirst Posted
Study publicly available on registry
November 4, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedJune 15, 2016
June 1, 2016
1.9 years
October 15, 2010
June 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Assessment for Living with Aphasia
A new, aphasia friendly measure based on the World Health Organization International Classification of Functioning, Disability, and Health. It is a specialized tool using a self-rating scale and is focused on specific themes that have emerged from previous research.
9 months
Secondary Outcomes (7)
Western Aphasia Battery - Revised
9 months
Successfully Living with Aphasia Rating Scale
9 months
Burden of Stroke Scale
9 months
Aphasia Depression Rating Scale
9 months
The Wepman Self-Correction Scale
9 months
- +2 more secondary outcomes
Study Arms (1)
Persons with Aphasia
Eligibility Criteria
Inpatient/outpatient hospital population
You may qualify if:
- years of age and older, willingness to be videotaped, first incidence of aphasia secondary to stroke with stroke onset ≤2.5
- months pre-stroke or 3.5 months post-stroke with no significant complicating concomitant conditions (e.g. dementia, schizophrenia),
- premorbid fluency/literacy in English, and no history of psychiatric disorder, and sufficient communication ability (including adequate hearing and vision) in English to participate in an interview as determined by a qualified speech pathologist based on administration of the Western Aphasia Battery - Revised and clinical observation.
- participants will be enrolled in the study at 3 months post onset (+/- 2 weeks) wherever they are living, and presence of aphasia will be confirmed at the beginning of the first interview using the Aphasia Quotient cut offs of the Western Aphasia Battery.
- participants with severe global aphasia will only be excluded after the interview if meaningful responses cannot be obtained using all available communication support tools. Hence, participants with a range of aphasia severity will be included.
You may not qualify if:
- unwillingness to be videotaped
- onset of stroke \<2.5 months post and \>3.5 months post
- moderate or severe dementia
- symptoms of another preexisting neurological condition other than or in addition to aphasia due to stroke, or drug abuse
- neurological surgical treatment not including a surgical treatment specifically for treatment of stroke, absence of aphasia.
- no subjects will have a hearing loss unexpected for his/her chronological age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- The Solomon Foundationcollaborator
- The University of Queenslandcollaborator
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martha T Sarno, MA,Dhonorary
NYU Langone Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 15, 2010
First Posted
November 4, 2010
Study Start
June 1, 2010
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
June 15, 2016
Record last verified: 2016-06